When exercise beats the prescription pad

There is no pill that does what exercise does. That's not a motivational poster — it's a clinical statement backed by decades of randomized evidence. For several of the conditions most commonly treated with medication, structured exercise is equally or more effective. And yet it's rarely prescribed with the same rigor.

Prediabetes: exercise wins

The Diabetes Prevention Program remains one of the most important prevention trials ever conducted. In 3,234 adults with prediabetes, intensive lifestyle intervention (7% weight loss + 150 min/week exercise) reduced progression to diabetes by 58%. Metformin — the most commonly prescribed diabetes prevention drug — reduced progression by 31%. Lifestyle intervention was nearly twice as effective as medication.

After 15 years of follow-up, the lifestyle group still had significantly lower diabetes rates than the metformin group. The effect was durable. And the lifestyle intervention had no side effects — only benefits.

Mild to moderate depression: exercise matches SSRIs

A meta-analysis published in the BMJ in 2024, pooling data from 218 studies and over 14,000 participants, found that structured exercise was as effective as SSRIs for treating mild to moderate depression. The effect was dose-dependent — more vigorous exercise produced larger benefits — and applied across age groups.

This doesn't mean people should stop their antidepressants. But it does mean that for many patients with mild to moderate symptoms, a serious exercise prescription (not "try to be more active") should be the first-line intervention — not the afterthought it typically is.

Hypertension: exercise delivers meaningful reduction

A meta-analysis of 391 randomized trials (n=39,742) published in the British Journal of Sports Medicine found that exercise reduced systolic blood pressure by 4.8 mmHg in people with hypertension — comparable to the effect of a first-line antihypertensive medication. For people with systolic BP above 140, the effect was even larger: 8.9 mmHg.

The implications are significant. For mild hypertension (stage 1, 130–140 mmHg systolic), exercise alone may be sufficient — potentially deferring medication entirely. For moderate hypertension, exercise alongside medication produces greater reductions than medication alone.

Cardiovascular risk: exercise is the foundation

As we discuss in our VO₂max article, cardiorespiratory fitness is the single strongest predictor of all-cause mortality. Each 1 MET improvement in fitness reduces mortality by 13%. No medication achieves this magnitude of risk reduction across such a broad range of outcomes.

Statins reduce cardiovascular events by about 22% per mmol/L of LDL-C reduction — an important effect in high-risk patients. But statins don't improve fitness, reduce depression, strengthen bones, prevent diabetes, or improve sleep. Exercise does all of these simultaneously.

When medication is still necessary

None of this means medication is unnecessary. For patients with established cardiovascular disease, diabetes, severe hypertension, or significant depression, medication is essential — often lifesaving. Exercise complements medication; it doesn't always replace it.

The point is this: in many patients at intermediate risk — the exact population most likely to undergo an executive health assessment — exercise is the most powerful intervention available, and it should be prescribed with the same specificity and follow-up as any drug.